Loading ...To medical professionals getting them to promote more killing my of people even kids.
Instead of questioning it’s lack of effectiveness, how it was derived and why, what’s in it, the adverse effects that should of shut them down already especially since the group NIH that caused the virus then partnering and profiting off it!! Pay the killer for killing and to kill some more. Recommend by the same groups that interfered with saving lives last time to promote the fake cure no less.
COVID vaccines will have a new formulation this year, according to a decision announced today by the US Food and Drug Administration that will focus efforts on circulating variants. The move pushes last year’s bivalent vaccines out of circulation because they will no longer be authorized for use in the United States.
The updated mRNA vaccines for 2023-2024 are being revised to include a single component that corresponds to the Omicron variant XBB.1.5. Like the bivalents offered before, the new monovalents are being manufactured by Moderna and Pfizer.
The new vaccines are authorized for use in individuals age 6 months and older. And the new options are being developed using a similar process as previous formulations, according to the FDA.
Targeting Circulating Variants
In recent studies, regulators point out the extent of neutralization observed by the updated vaccines against currently circulating viral variants causing COVID-19, including EG.5, BA.2.86, appears to be of a similar magnitude to the extent of neutralization observed with previous versions of the vaccines against corresponding prior variants.
BS BS and BS Never mind those dead people over there.
“Vaccination remains critical to public health and continued protection against serious consequences of COVID-19, including hospitalization and death,” Peter Marks, MD, PhD, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement. “The public can be assured that these updated vaccines have met the agency’s rigorous scientific standards for safety, effectiveness, and manufacturing quality. We very much encourage those who are eligible to consider getting vaccinated.”
Timing the Effort
The US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will meet tomorrow to discuss clinical recommendations on who should receive an updated vaccine, as well as further considerations for specific populations such as immunocompromised and older people.
Manufacturers have publicly announced that updated vaccines will be ready this fall and the FDA says it anticipates the updated vaccines will be available soon.